Prevalence of hepatitis B and C virus seropositivity among tribal and non-tribal voluntary blood donors of Rangamati, Bangladesh

Dewan, Gourab

doi:10.3126/jucms.v1i4.9571

Cited by 3 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The possible routes of transmission of HBV among tribes are perinatal transmission, accidental inoculation of contaminated blood during cultural practices like tattooing and nose/ear pricking, polygamy or multiple sexual partners, horizontal transmission through close personal contacts or through blood and body fluid contamination. 8 Carrier stage among tribes is found to be high varying anywhere from 8% to 21%, but community related risk yet not clarified in any of the groups by previous studies. 4 In our study none turned out to be positive for HBsAg, which is contradictory to the previous studies.…”

Section: Discussionmentioning

confidence: 82%

Null Seroprevalence of Hbsag Carrier State Among Kurichiya Tribal Community Around Kannur, Kerala, India

Shyamala¹,

Ismail²,

Bijapur³

et al. 2016

Int. J. Res. Ayurveda Pharm.

View full text Add to dashboard Cite

Hepatitis B virus infection is one of the major public health concern, with about 2 billion people infected globally and >350 million chronic carriers of the virus, of which >40 million are from India. India falls under intermediate zone of endemicity with a carrier rate anywhere between 2-4%. Prevalence of disease is much higher among tribal groups and the cause for this is geographical isolation, culture, apathy towards health seeking behavior. Aim of the study was to determine the prevalence of Hepatitis carrier rate. We conducted a study to derive HBsAg determination among kurichiya tribal group in and around Kannur, northern Kerala, India. ELIFA method was used to determine HBsAg from serum samples of the study group. There was null HBsAg seropositivity among the kurichiya community. This community is considered as the highly sophisticated community out of 63 other communities. Kurichiya's are highly known for maintaining antisepsis and sterilization procedures. We found that the risk factors for transmission of Hepatitis are negligible. The null positivity of HBsAg carrier among the tribes gives insight into the Kurihiya community about their lifestyles and practices. Significance of folk medicine needs to be extensively studied in a systematic manner.

show abstract

Section: Discussionmentioning

confidence: 82%

Null Seroprevalence of Hbsag Carrier State Among Kurichiya Tribal Community Around Kannur, Kerala, India

Shyamala¹,

Ismail²,

Bijapur³

et al. 2016

Int. J. Res. Ayurveda Pharm.

View full text Add to dashboard Cite

show abstract

“…The result revealed a HBsAg seropositivity of 1.5% among all first-time donors, similar to findings from previous studies conducted among blood donors in Khulna and in Rangamati, Bangladesh, which estimated a prevalence of 1.1-1.4%. 19,20 In contrast, previous studies among high-risk groups of transfusion-transmitted infections (TTIs) in Bangladesh reported higher prevalences of HBV infection, ranging from 3.8% to 9.7%. 1,9,11,17,[21][22][23] The prevalence of HBV infection among blood donors in our study was similar with those reported by studies conducted in nearby countries (India, Pakistan, and China) in 2013.…”

Section: Discussionmentioning

confidence: 93%

Seroprevalence of Hepatitis B Infection among First-Time Blood Donors in Faridpur, Bangladesh: A Cross-sectional Study

Biswas

2016

Int J Med Students

View full text Add to dashboard Cite

Background: Hepatitis B infection is a global threat for people of all age groups and is common in Bangladesh and other South Asian countries. Blood donors and blood donation can present important risk for hepatitis B infection. Our objective was to identify seroprevalence of hepatitis B virus among blood donors in Faridpur, Bangladesh. Methods: A cross-sectional study was conducted among 719 blood donors in the Faridpur district of Bangladesh from April to July 2013. Data was collected by non-probability convenient sampling maintaining inclusion and exclusion criteria. Face-to-face interview, blood grouping test, and hepatitis B surface antigen (HBsAg) screening were conducted. Results: About 30% of the blood donors were between 19 and 23 years of age, and 87.5% of them were males. Two-thirds (64.1%) of the donors were replacement donors, while the remaining 35.9% of them were voluntary donors. The overall seropositivity of HBsAg was found to be 1.5%. All infected blood donors were males. Hepatitis B infection was more prevalent in the 34–38 years age group and least prevalent among those older than 48 years of age. About 2% of replacement blood donors were infected with hepatitis B virus, compared to 0.7% among voluntary blood donors. Conclusion: Hepatitis B infection among blood donors is relatively lower than in other high-risk groups for hepatitis B infection in Bangladesh. Predominance of HBsAg among older adult groups, replacement donors, and the male gender can be a matter of public health concern.

show abstract

Profiling of antioxidant properties and identification of potential analgesic inhibitory activities of Allophylus villosus and Mycetia sinensis employing in vivo, in vitro, and computational techniques

Azam,

Biswas,

Khandker

et al. 2024

Journal of Ethnopharmacology

View full text Add to dashboard Cite

Prevalence of hepatitis B and C virus seropositivity among tribal and non-tribal voluntary blood donors of Rangamati, Bangladesh

Cited by 3 publications

References 8 publications

Null Seroprevalence of Hbsag Carrier State Among Kurichiya Tribal Community Around Kannur, Kerala, India

Null Seroprevalence of Hbsag Carrier State Among Kurichiya Tribal Community Around Kannur, Kerala, India

Seroprevalence of Hepatitis B Infection among First-Time Blood Donors in Faridpur, Bangladesh: A Cross-sectional Study

Profiling of antioxidant properties and identification of potential analgesic inhibitory activities of Allophylus villosus and Mycetia sinensis employing in vivo, in vitro, and computational techniques

Contact Info

Product

Resources

About